This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kunnumakkara, A. B. Articles by Krishnan, S. Search for Related Content PubMed PubMed Citation Articles by Kunnumakkara, A. B. Articles by Krishnan, S.

Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to -Radiation by Targeting Nuclear Factor-B–Regulated Gene Products

Authors' Affiliations: Departments of ¹ Experimental Therapeutics, ² Radiation Oncology, and ³ Gastroenterology, Hepatology and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Sunil Krishnan, Box 97, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-563-2377; E-mail: skrishnan{at}mdanderson.org or Bharat B. Aggarwal, Box 143, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-794-1817; Fax: 713-745-6339; Email: aggarwal{at}mdanderson.org.

Purpose: How colorectal cancer develops resistance to -radiation is not fully understood, but the transcription factor nuclear factor-B (NF-B) and NF-B–regulated gene products have been proposed as mediators. Because curcumin, a component of turmeric (Curcuma longa), has been shown to suppress NF-B activation, whether it can sensitize the colorectal cancer to -radiation was investigated in colorectal cancer xenografts in nude mice.

Experimental Design: We established HCT 116 xenograft in nude mice, randomized into four groups, and treated with vehicle (corn oil), curcumin, -radiation, and curcumin in combination with -radiation. NF-B modulation was ascertained using electrophoretic mobility shift assay and immunohistochemistry. Markers of proliferation, angiogenesis, and invasion were monitored by immunohistochemistry and Western blot analysis.

Results: Curcumin significantly enhanced the efficacy of fractionated radiation therapy by prolonging the time to tumor regrowth (P = 0.02) and by reducing the Ki-67 proliferation index (P < 0. 001). Moreover, curcumin suppressed NF-B activity and the expression of NF-B–regulated gene products (cyclin D1, c-myc, Bcl-2, Bcl-xL, cellular inhibitor of apoptosis protein-1, cyclooxygenase-2, matrix metalloproteinase-9, and vascular endothelial growth factor), many of which were induced by radiation therapy and mediate radioresistance. The combination of curcumin and radiation therapy also suppressed angiogenesis, as indicated by a decrease in vascular endothelial growth factor and microvessel density (P = 0.002 versus radiation alone).

Conclusion: Collectively, our results suggest that curcumin potentiates the antitumor effects of radiation therapy in colorectal cancer by suppressing NF-B and NF-B–regulated gene products, leading to inhibition of proliferation and angiogenesis.

This article has been cited by other articles:

				B. Sung, A. B. Kunnumakkara, G. Sethi, P. Anand, S. Guha, and B. B. Aggarwal Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model Mol. Cancer Ther., April 1, 2009; 8(4): 959 - 970. [Abstract] [Full Text] [PDF]

				D. Wang, M. S. Veena, K. Stevenson, C. Tang, B. Ho, J. D. Suh, V. M. Duarte, K. F. Faull, K. Mehta, E. S. Srivatsan, et al. Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor {kappa}B by an AKT-Independent Pathway Clin. Cancer Res., October 1, 2008; 14(19): 6228 - 6236. [Abstract] [Full Text] [PDF]